Search research articles
Contact Us
Filters
Showing results (71-80 of 74) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 74 results.
Cytotherapy
|
June 19, 2007
Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age
G Milone, S Mercurio, A Strano, et al.
Leukemia
|
June 22, 2001
Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis
F Di Raimondo, M P Azzaro, G A Palumbo, et al.
American Journal of Human Genetics
|
March 26, 1999
Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population
I Aksentijevich, Y Torosyan, J Samuels, et al.
Leukemia
|
May 24, 2003
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols
F Mandelli, R Latagliata, G Avvisati, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 74) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 74 results.
Cytotherapy
|
June 19, 2007
Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age
G Milone, S Mercurio, A Strano, et al.
Leukemia
|
June 22, 2001
Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis
F Di Raimondo, M P Azzaro, G A Palumbo, et al.
American Journal of Human Genetics
|
March 26, 1999
Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population
I Aksentijevich, Y Torosyan, J Samuels, et al.
Leukemia
|
May 24, 2003
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols
F Mandelli, R Latagliata, G Avvisati, et al.
Page
of 8